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Xenotransplantation of porcine islets to human recipients is being investigated as a 
potential cure for type 1 diabetes. The objective of the study was to evaluate effects of laser 
therapy on insulin secretion in pig islets. Sixteen pig pancreata were harvested for islet 
isolation. Islets were treated with laser dosages of 5J - 25J followed by 30, 20 or 10-minute 
incubation in low (3.0 mM) or high (16.7 mM) glucose. Insulin secretion was higher in 
samples exposed to 5J laser therapy followed by a 30-minute culture in low glucose (P ≤ 
0.05). When evaluating gender differences, male islets had an increased insulin secretion in 
low glucose (P ≤ 0.05) compared to females. No significant differences were seen in high 
glucose. In conclusion, laser therapy increased insulin secretion on pig islets in low glucose 
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Type 1 Diabetes 
 Diabetes affects more than 300 million people across the world with an estimated 1.5 
million people suffering from type 1 diabetes in the United States alone (Sherwin and 
Jastreboff, 2012; Van der Windt et al., 2012). Type 1 diabetes is a chronic condition where 
the pancreas produces little to no insulin. This is due to the body’s immune system 
destroying the islets in the pancreas. This results in high concentrations of glucose in the 
bloodstream which can cause hyperglycemia. Hyperglycemia can cause adverse issues such 
as heart failure, stroke, blindness, kidney damage and nerve damage (Dokken, 2008; 
Pietrangelo and Cherney, 2017). The current treatment for type 1 diabetes is insulin 
injections or an insulin pump to help regulate glucose levels within the body.  
In a healthy individual, the body breaks down carbohydrates into glucose which then 
gets passed into the bloodstream for use in the body’s tissues as an energy source. The islets 
in the pancreas detect the rise in glucose present in the bloodstream and begin to secrete 
insulin from β cells within the islets. Insulin is the hormone that allows the body’s tissue to 
absorb glucose.  
Islet Transplantation 
Pancreatic islet transplantation is a potential cure for type 1 diabetes. Compared to a 
pancreas transplantation, islet transplantation is not as invasive and is more easily tolerated 
(McCall and Shapiro, 2012). The expected outcome is insulin independence and stabilized 
__________________________________________________ 
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blood glucose resulting in transplantation as a promising treatment for future diabetes 
patients (Zinger and Leibowitz, 2017). However, there are a limited number of suitable donor 
pancreata, so the number of patients able to be treated is also small (Van der Windt et al., 
2012). Another major obstacle faced includes the loss of healthy, functional islets during 
transplantation due to a high rejection rate of the porcine islets by the immune system of the 
recipient (Irani et al., 2009). Immunosuppression is required for the immune system to accept 
the transplanted islets; however, this increases the risk of infection for the recipient. 
Inflammation has also been seen after islet transplantation due to the body’s natural 
inflammatory response.  While human islet transplantation has proven to be successful in 
limited cases, research is needed to improve this success rate. Therefore, porcine (pig) islets 
are being considered due to their shared similarities with humans which include omnivorous 
habits as well as similar metabolic and cardiovascular features (Torres-Rovira et al., 2012). 
The use of pig islets for research holds great promise for largescale application of islet 
transplantation (Ferrer et al., 2008). 
Xenotransplantation  
 Xenotransplantation is the process of transplanting organs or tissues between different 
species. It has been previously proven that transplanted pig islets could uphold normal 
glycemia levels in diabetic non-human primates for a period greater than 6 months and in 
some cases up to 1 or 2 years. A study utilizing an in vitro perifusion system found isolated 
pig islets demonstrate a biphasic insulin secretion pattern stimulated by glucose, which is a 
common pattern also found in insulin secretion of humans (Cooper et al., 2016). However, 
islet xenotransplantation faces many challenges. One of the main challenges includes the fact 
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that pig islets have poor sensitivity to glucose which results in poor insulin production when 
compared to human islets (Cooper et al., 2016). 
Objective 
 Previous research found that phototherapy has increased the amount of insulin 
secreted when applied to islets. Therefore, the objective of this study was to evaluate the 

















Phototherapy has been found to increase cellular proliferation of fibroblasts and 
stimulate secretion from secretory cells (Kamrani et al., 2008). These effects can be 
explained by the increase in adenosine triphosphate (ATP) which results in DNA synthesis. 
The content of ATP within the cell is a significant factor for increasing the islet insulin 
secretion (Kamrani et al., 2008). This is observed by the preserving characteristic 
phototherapy has on the mitochondria within the cell (Oron et al., 2007). Previous research 
has evaluated the effects of infrared light and laser therapy, specifically.  
Infrared Light 
Infrared (IR) light’s impact on increasing insulin secretion in rats was found to not 
cause any damage to cell viability. Islets exposed to IR light did not have a decreased final 
insulin production normally observed after incubation (Meulenaer et al., 2009). On the 
second day after exposure, the number of cells recovered was significantly higher after 
exposure to IR because it promotes and favors growth of cells. Treatment with IR light had 
several favorable effects on the function of islets including the stimulation of cell growth, an 
increase in intracellular ATP content and insulin production (Meulenaer et al., 2009). 
Low Level Laser Therapy  
 Low level laser therapy (LLLT) could improve rodent islet viability and function 
prior to transplantation (Irani et al., 2009). Many studies have shown in vitro laser therapy 
can accelerate the repair process as well as stimulate rapid cellular reproduction (Kamrani et 
al., 2008). Increased intracellular ATP results in DNA synthesis and helps explain the effects 
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of the rapid cellular reproduction after LLLT. Also, LLLT can increase the function of 
insulin secretion as well as its viability due to the increase in intracellular ATP and calcium 
influx (Kamrani et al., 2008). It was also found that the islet walls were not damaged after the 
laser therapy. 




MATERIALS AND METHODS 
Porcine Pancreas Procurement  
 A total of 16 pancreata from adult pigs were collected at a USDA inspected animal 
harvest facility. Animals were harvested under USDA humane handling and harvest 
protocols; as such IACUC approval requirements have been waived by the IACUC 
committee. After animal harvest, pancreas procurement began by cutting small masses of the 
pancreas out and trimming the mass into smaller pieces approximately 2.54 cm3 in size. 
These pancreas sample pieces were placed into a CoStorSol University of Wisconsin (UW) 
cold storage washing solution (Preservation Solution Inc., WI, USA) for 5 seconds. The 
pieces were then placed into a sterile container containing 35 mL of fresh UW washing 
solution.  
Islet Isolation and Culture 
 Islet isolation was completed in two distinct steps: pancreas digestion and islet 
purification. Pancreas digestion included eliminating other pancreatic cells from the sample 
by sectioning the pancreas and then exposing it to enzymatic digestion. This process began 
by trimming the pancreas samples to eliminate adipose and connective tissue approximately 
40 to 60 minutes after harvest. Once all extra tissue was trimmed off, the pancreas was cut 
into smaller pieces and transferred to new sterile tubes where 15 mL UW solution was added. 
The islet purification step involved procuring the remaining islets to ensure higher quality 
samples and results for testing (McCall and Shapiro, 2012). This was done by adding a 
concentrated enzyme solution, Liberase DL (Sigma Aldrich, USA), in the concentration of 
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0.83mg/mL to promote digestion of the pancreas tissue. These tubes were incubated on a 
rotator at 37°C for 30 minutes.  
 Enzymatic digestion was stopped by adding cold Roswell Park Memorial Institute 
(RPMI) medium including 5% newborn calf serum (NCS) to the full volume of the tube. The 
RPMI medium is commonly used in cell cultures and tissue cultures because the medium is 
designed to promote the growth of mammalian cells. The solution was mixed slowly for 30 
seconds and then stood still for 3 minutes to allow the tissue samples to settle completely to 
the bottom. The supernatant (SN) was pipetted out into a waste beaker. This washing process 
occurred one more time. Fresh RPMI medium with 5% NCS was added to reach a total 
volume of 30 mL and the tubes were placed in a centrifuge at 1500 G for 3 minutes at 4°C. 
 The SN was poured off into a waste beaker and plain UW solution was added to the 
tissue sample for a total volume of 12.5 mL. A working optiprep solution (1 part optiprep 
with 1 part plain UW solution) was added in the amount of 10 mL to each sample followed 
by adding 8 mL of an optiprep RPMI-1640 medium solution (9.1 mL optiprep, 25 mL plain 
RPMI and 0.696 mL of HEPES (a zwitterionic organic chemical buffering agent)). Each tube 
was filled to reach a total volume of 40 mL using plain RPMI medium solution and 
centrifuged at 500 G for 5 minutes at 4°C. The islets were transferred to 150 mm dishes 
containing 20 mL of an RPMI medium solution that includes 10% porcine serum and 1% of 
Anti-Anti (antibiotic-antimycotic) solution. Samples were cultured overnight in a 37°C and 
5% CO2 environment. The number of islets collected from each pancreas varied; therefore, 




Low Level Laser Therapy on Islets 
 Study 1: The islets were transferred back into tubes (2 dishes per tube) and placed in 
the centrifuge at 4500 G for 3 minutes at room temperature (RT). The SN was removed until 
approximately 1 to 2 mL was left in the 50 mL tube and each tube was transferred into a 
microcentrifuge tube. The microcentrifuge tubes were spun down at a benchtop centrifuge 
(Labnet International Inc., Cat. No.: C1201) at 6000 rpm for 30 seconds at RT. The SN was 
removed completely and 600 µL of plain RPMI medium solution was added to the islet 
samples. Next, 75 µL of the islet sample from each tube was transferred into eight separate 
wells in a 96-well microplate. A low glucose (3.0 mM) and high glucose (16.7 mM) media 
was made by using the RPMI medium solution (Appendix). The glucose media was added to 
the samples in designated wells. The laser (JDSU HeNe, model number: 1508-1) treatment 
was applied at various treatment time intervals, and the islets were cultured for 30 minutes in 
a 37°C environment with no cover (Table 1).  
Study 2: The isolation process from Study 1 remained the same. Differences were 
seen when the islet samples were divided roughly into thirds before being loaded to the 
microplates. Each third of the islet sample was placed into 6 separate wells in one of the 96-
well microplates. The same low and high glucose media from study 1 was made and added to 
the samples in designated wells. The laser treatment was applied at various treatment time 
intervals, and the first microplate was cultured for 30 minutes in a 37°C environment with no 
cover. The second and third microplates also received the same laser treatment at various 
treatment time intervals. The second microplate was cultured for 20 minutes and the third 
microplate was cultured for 10 minutes, both in a 37°C environment with no cover (Table 2).  
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Table 1. Levels of Laser Therapy Applied to Isolated Porcine Islets in Low and High 
Glucose Concentrations Based on Time Exposed to Laser for Study 1 
Laser Dosage: 633 nm  
(joules) 
Low Glucose: 3.0 mM 
(seconds) 
High Glucose: 16.7 mM 
(seconds) 
0 0 0 
5 9 9 
10 18 18 
15 27 27 
20 36 36 





Table 2. Levels of Laser Therapy Applied to Isolated Porcine Islets in Low and High 
Glucose Concentrations Based on Time Exposed to Laser for Study 2 
 
Laser Dosage: 633 nm  
(joules) 
Low Glucose: 3.0 mM 
(seconds) 
High Glucose: 16.7 mM 
(seconds) 
0 0 0 
5 9 9 




After the culture period, the samples were then collected into microcentrifuge tubes 
and placed in the benchtop centrifuge at 6000 rpm for 60 seconds at RT. The SN was 
collected for an Insulin ELISA assay and placed into a separate tube leaving behind the islets 
in the original tube. All samples underwent snap freezing using liquid N2 and placed in a -
80°C freezer for future testing.  
Insulin Secretion Assay 
A Porcine/Canine Insulin ELISA assay (ALPCO, NH, USA) was utilized to measure 
the concentration of insulin present in samples from both study 1 and 2. The kit contained a 
conjugate stock, wash buffer concentrates and two controls (levels 2 and 3) that were 
prepared for future use. Each standard, control and SN samples were pipetted into their 
respective wells on a 96-well microplate at a volume of 25 µL each. A working strength 
conjugate stock was added to each well at a volume of 75 µL. The microplate was covered 
with a microplate sealer and incubated at RT for 2 hours, shaking at 700-900 rpm on a 
microplate shaker. At the end of the 2 hours, the contents of the wells were decanted, and the 
microplate was washed 6 times with the working strength wash buffer. A TMB substrate 
solution was added to each well at a volume of 100 µL, the microplate was covered again 
and incubated for 15 minutes at RT, shaking at 700-900 rpm on a microplate shaker. Once 
this is done, 100 µL of a Stop solution was added to each well of the microplate and the 
absorbance was measured using a microplate reader (BIO RAD iMark®, VT, USA).  
Total Protein Extraction  
Insulin secretion was normalized by measuring the total tissue volume (total protein 
concentration) to account for variation in the number of islets for each sample. This was 
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completed by setting the islet samples on ice while a Triton extraction buffer (100 µL of 10 
mM TRIS HCL, 300 µL of 150 mM NaCl, 100 µL of 5mM EDTA, 200 µL of 20 mM Na 
Molybdate, 1000 µL of 50 mM Na Fluoride, 20 µL of 0.2mM Na Orthovanidate, 1000 µL of 
2% Triton X-100, 7280 µL of Di H2O and 10 µL of phenylmethylsulfonyl fluoride (PMSF)) 
was made. Once made, 100 µL of the extraction buffer was added to each islet sample and 
mixed thoroughly to initiate the breakdown of the cell membrane and to expose the protein 
concentration. The samples were then placed back on ice for 30 minutes before being 
centrifuged at 16,000 G at 4°C for 30 minutes.  
After centrifugation, the SN was extracted out and into a new tube leaving behind the 
remaining broken-down cell components. The SN was run through a BCA Protein Assay Kit 
(Pierce, IL, USA) to determine the protein concentration present. The standards and samples 
were pipetted into their respective wells on a 96-well microplate at a volume of 25 µL each. 
A working reagent (WR) was prepared using two reagents (reagent A and B) provided in the 
assay kit into a concentration of 50 parts reagent A to 1 part reagent B. Two hundred µL of 
the WR was added into each well and the entire microplate was placed on a microplate 
shaker for 30 minutes. The microplate was then covered and incubated at 37°C for 30 
minutes. At the end of the 30 minutes, the microplate was cooled to RT and the absorbance 
was measured using a microplate reader (BIO RAD iMark®, VT, USA). Variation in insulin 
secretion/total protein concentrations between each pig was observed, therefore each pig was 
normalized to its own control before comparing to other pigs. 
Statistical Analysis 
Data was analyzed using IBM-SPSS Statistics (version 21). For data sets with one 
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independent variable, a one-way ANOVA was initially applied. The data did not fit a normal 
distribution nor had equal variance. Therefore, Kruskal-Wallis, non-parametric test was 
applied. For data sets with two independent variables, a two-way ANOVA was initially 
applied. For those with an interaction, a one-way ANOVA with a Fisher’s LSD post hoc test 
was applied where normal distribution and equal variance was met. Significant differences 
















One Independent Variable  
Multiple data sets were comprised based on comparisons of interest. First, data from 
Study 1 (n = 8) was ran through statistical analyses and no significant differences between 
laser treatment applications were found in either the low (Figure 1a) or high glucose media 
(Figure 1b). Three data sets from Study 2 (n = 8) were comprised from the three different 
incubation periods. The 30-minute incubation period showed significant differences (P = 
0.043) in the low glucose; the 5J laser dosage increased the amount of insulin secreted 
compared to the control (Figure 2a). However, no significances were seen in the high glucose 
(Figure 2b).  There were no significant differences seen in the 20-minute low (Figure 3a) and 
high glucose media (Figure 3b) or for the 10-minute low (Figure 4a) and high glucose media 
(Figure 4b). Data sets from combining 0J, 5J and 10J dosages from Study 1 and the 30-
minute incubation period from Study 2 (n = 16) resulted in no significant differences in the 
low (Figure 5a) and high glucose media (Figure 5b).  
Two Independent Variables 
 The combined data from Study 1 and Study 2 was utilized again and blocked by 
gender (n = 10, male; n = 6, female). Significant differences were found in the male islets in 
the low glucose media. Insulin secretion was increased in the male islets receiving the 5J 
laser dosage compared to the male control (P = 0.037), compared to the female islets 
receiving the 5J laser dosage (P = 0.031), and the male islets compared to the female islets 
exposed to the 10J laser dosage (P = 0.020) (Figure 6a). There were no significant 
differences seen in the high glucose media when comparing genders (Figure 6b). 
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Figure 1a. Percentage of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media  
(3.0 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 (n = 8) 
-All measurements were normalized to the control 




Figure 1b. Percentage of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 (n = 8) 
-All measurements were normalized to the control  














































































Figure 2a. Percentages of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media  
(3.0 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 2 (n = 8) 
-All measurements were normalized to the control  
-The bar with an asterisk (*) represents a significance difference 




Figure 2b. Percentages of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 2 (n = 8) 
-All measurements were normalized to the control  












































































(P = 0.043) 
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Figure 3a. Percentages of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media 
(3.0 mM) at a 20-Minute Incubation Period Based on Different Dosages of LLLT 0633 nm) 
for Study 2 (n = 8) 
-All measurements were normalized to the control  




Figure 3b. Percentages of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 20-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 2 (n = 8) 
-All measurements were normalized to the control  















































































Figure 4a. Percentages of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media  
(3.0 mM) at a 10-Minute Incubation Period Based on Different Dosages of LLLT (633nm) 
for Study 2 (n = 8) 
-All measurements were normalized to the control  




Figure 4b. Percentages of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 10-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 2 (n = 8) 
-All measurements were normalized to the control  














































































Figure 5a. Percentages of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media 
(3.0 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 combined with Study 2 (n = 16) 
-All measurements were normalized to the control 





Figure 5b. Percentages of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 combined with Study 2 (n = 16) 
-All measurements were normalized to the control  













































































Figure 6a. Percentages of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media 
(3.0 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 combined with Study 2 Blocked by Gender (n = 10, male; n = 6, female) 
-All measurements were normalized to the control  
-Bracketed bars with an asterisk (*) represent significance differences  




Figure 6b. Percentages of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT 9633 nm) 
for Study 1 combined with Study 2 Blocked by Gender (n = 10, male; n = 6, female) 
-All measurements were normalized to the control  




















































































The combined data from Study 1 and Study 2 was blocked based on the different 
harvesting process (n = 10, tumbled; n = 6, skinned). This was dependent on whether the pig 
was placed in a tumbler to singe off the hair (tumbled) or if it was skinned which removes the 
hide during the harvesting process. This data comparison showed no significant differences 






































Figure 7a. Percentages of Insulin Secretion/Total Protein (ng/mg) in Low Glucose Media 
(3.0 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 combined with Study 2 Blocked by Harvesting Process (n = 10, tumbled; n = 6, 
skinned) 
-All measurements were normalized to the control  




Figure 7b. Percentages of Insulin Secretion/Total Protein (ng/mg) in High Glucose Media 
(16.7 mM) at a 30-Minute Incubation Period Based on Different Dosages of LLLT (633 nm) 
for Study 1 combined with Study 2 Blocked by Harvesting Process (n = 10, tumbled; n = 6, 
skinned) 
-All measurements were normalized to the control  















































































The objective of this study was to investigate whether laser therapy would increase 
insulin secretion on isolated porcine islets that were tested in low and high glucose media.  
In study 1, no significant differences were found after a 30-minute incubation period 
under laser dosages between 5J and 25J. Although not statistically significant, the results 
from this study did show the islets receiving the 15J laser dosage released less insulin than 
the control, therefore it can be suggested that the dosages of 10J or less might be more 
promising and were focused on for study 2.  
Past literature over other sensory cells also favored 10 and 20-minute incubation 
periods after laser treatment where peaks in secretion were documented (Oron et al., 2007, 
Karu et al., 1995). Therefore, the method for study 2 includes 30, 20 and 10-minute 
incubation periods to determine if incubation time could play a role in insulin secretion. The 
5J laser dosage with a 30-minute incubation period in low glucose was the most optimal over 
the other dosages and incubation periods.  
Therefore, the lack of significant differences found in study 1 could be due to the high 
variation in incubation time observed because of the initial design. Study 1 had a larger 
incubation interval between the first and last samples after the laser therapy because there 
were more samples within the microplate. Whereas, Study 2 had fewer samples within each 
microplate, resulting in less variance in the culture times between the first and last samples.  
When combining study 1 and study 2 (n = 16 at dosages of 0J, 5J and 10J for a 30-
minute incubation), no significance differences were found. Again, it is inferred that the high 
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variation observed within study 1 was too large to compensate for given the restricted sample 
size. However, a further analysis was conducted researching gender differences. The results 
from this study show a higher sensitivity in male islets versus female islets; as they had an 
increased response in insulin secretion to the laser therapy. There are limited articles on the 
differences of islets between genders. Only one study suggested that insulin content was 
similar when comparing male and female islets in mice (Strandell and Sandler, 1997). 
Therefore, this could be the first report showing a significant difference to stimulants such as 
LLLT in this study islet based on gender.  
The viability of the islets was being questioned on the quality of the pancreas sample 
collected which varied based on the harvesting process. The tumbling process seemed to be 
slightly shorter, but not by much time. Simply comparing one process against the other 
showed no apparent differences found. Therefore, future research should not need to take 
into consideration the differences in the harvesting procedures. 
All significant differences were observed in low glucose media rather than the high 
glucose media. In addition, high glucose did not seem to increase insulin significantly both 
with and without LLLT. This was in agreement with previous literature where isolated pig 
islets did not respond significantly to high glucose for insulin secretion (Cooper et al., 2016). 
However, LLLT does not seem to improve this characteristic either. 
Limitations 
 Due to limited availability of porcine subjects and the sampling environment, there 
was variation within the pig selection process including harvesting the pancreas and the 
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purification of the islets. In order to retrieve enough yield of isolated islets for each trial, 
during the isolation process, there were non-islet cell tissue debris within the samples. There 
was also a time gap limitation in the laser therapy procedure; the first well had a longer 





  In conclusion, laser therapy significantly increased insulin secretion on pig islets in 
low glucose media at a dosage of 5J.  Laser therapy also increased insulin secretion in male 
pig islets in low glucose at 5J compared to its control and at 5J and 10J compared to the 
female islets. Future research should further investigate modifications in the harvesting 
procedure that will allow for a shorter collection time of samples. There is also a need for an 
improved isolation process that result in more purified islets before transplantation is 
possible. The laser therapy should be focused on 10J or less; the 15J dosage and higher 
seemed to decrease the viability of the islets. Additional avenues of research include further 
investigation of the role gender plays on the viability and sensitivity of islets. A follow up 
study can focus on a perifusion system for the isolated islets which more closely mimics the 
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 200 mM Glucose Plain RPMI 
Low Glucose (3.0 mM) 150 µL 4,850 µL 
High Glucose (16.7 mM) 835 µL 4,165 µL 
-200 mM Glucose = 1.8 g of Glucose in 1000 mL of Plain RPMI 
-Low Glucose at 3.0 mM = 54 mg/dL = fasting glucose level 
-High Glucose at 16.7 mM = 300 mg/dL = postprandial glucose level 
 
